Background
Thioredoxin reductase 1
(
TXNRD1
) is an antioxidant enzyme reportedly overexpressed in hepatocellular carcinoma (HCC); however, the detailed function and mechanisms of TXNRD1 in HCC remain obscure. In this study, we investigated the miR-125b-5p-specific regulation of
TXNRD1
levels and its effect on HCC cells.
Methods
We detected miR-125b-5p levels in human HCC tissue samples through quantitative reverse transcription polymerase chain reaction (qRT-PCR), and in vitro experiments were employed to investigate the effect of miR-125b-5p on HCC cell proliferation, migration, and invasion. Additionally, we examined miR-125b-5p-mediated changes in TXNRD1 levels by qRT-PCR and western blotting, and a dual luciferase-reporter assay was conducted to confirm direct targeting of the 3′ untranslated region of TXNRD1 mRNA by miR-125b-5p.
Results
miR-125b-5p expression was reduced in HCC tissues relative to that in matched para-carcinoma tissues; this finding was verified in HCC cohorts from the Gene Expression Omnibus and The Cancer Genome Atlas. Additionally, low miR-125b-5p expression was associated with poor prognosis in HCC patients, and gene-set enrichment analysis indicated that miR-125b-5p levels were associated with HCC proliferation and metastasis. As predicted, overexpressing miR-125b-5p restrained the proliferation, migration, and invasion of Huh7 and SK-Hep-1 cells and forced expression of the miR-125b-5p-downregulated TXNRD1 mRNA and protein levels in HCC cells. Moreover, dual luciferase-reporter assays revealed that miR-125b-5p targets
TXNRD1
to directly regulate its expression, whereas
TXNRD1
overexpression abolishes the inhibitory effect of miR-125b-5p on HCC cell proliferation, migration, and invasion.
Conclusions
These results demonstrated miR-125b-5p as a tumor suppressor in HCC through its inhibition of
TXNRD1
, thereby suggesting it as a potential target for the clinical treatment of HCC.
Electronic supplementary material
The online version of this article (10.1186/s12935-019-0919-6) contains supplementary material, which is available to authorized users.